Ranbaxy given tentative approval for overactive bladder treatment
20th Sep 2005, 02:02 GMT
Ranbaxy Laboratories has received tentative approval from the FDA to manufacture and market tolterodine tartrate tablets, its generic equivalent of Pfizer's Detrol tablets.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol